Previous 10 | Next 10 |
Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research PR Newswire SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Swi...
Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing PR Newswire SOPHiA GENETICS technology will help increase cancer research abilities BOSTON and LAUSANNE, Switzerland , May 16, 2023 /PRNewswire/...
Dasa Expands Its Capabilities with SOPHiA GENETICS PR Newswire In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed BOSTON and LAUSANNE, Switzerland , May 8, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud...
2023-05-13 05:34:01 ET SOPHiA GENETICS SA (SOPH) Q1 2023 Earnings Conference Call May 09, 2023 08:00 AM ET Company Participants Katherine Bailon - Vice President of Investor Relations Jurgi Camblong - Co-Founder and Chief Executive Officer Ross Muken - Chief Fina...
2023-05-09 07:01:16 ET SOPHiA Genetics press release ( NASDAQ: SOPH ): Q1 GAAP EPS of -$0.31 beats by $0.01 . Revenue of $14M (+28.9% Y/Y) beats by $0.11M . The company reiterated full-year guidance including reported revenue growth expected to be at or above 3...
BOSTON and LAUSANNE, Switzerland, May 09, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the first quarter ended March 31, 2023. Recent Highlights Revenue for the first...
SOPHiA GENETICS expands footprint in India as Unipath Specialty Laboratory Limited is now live on SOPHiA DDM™ HRD Solution SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Unipath Sp...
Recognition by the Swiss Biotech Association for SOPHiA GENETICS’ Outstanding Contributions as a Leader in Data-Driven Medicine SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, was honored to accept the ...
BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the first quarter of fiscal 2023 before U.S. markets open on Tuesday, May 9, 2...
SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the University of Maryland Medical...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...